The production of vaccines against COVID-19 as an input for the competitiveness of the Argentine pharmaceutical sector
DOI:
https://doi.org/10.48160/25913530di15.167Abstract
The COVID-19 pandemic has set off health alarms around the world, prompting major pharmaceutical laboratories to rapidly develop vaccines to fight the virus. Developed countries produced the first vaccines, leading the periphery not only in the production of these drugs but also in distribution. However, Argentina has signed local production agreements for vaccines produced in developed countries. It should not be ignored that Argentina is one of the countries in the region with local production and export skills. Considering this capabilities, this work examines the possibilities that local production of vaccines against COVID-19, represent as an instrument of competitiveness of the Argentine pharmaceutical sector, based on certain vectors of competitiveness and the projections that the sector has made for 2025, in a scenario prior to this global phenomenon.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Divulgatio. Academic postgraduate profiles
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
AUTORIZACIÓN DE CESIÓN NO EXCLUSIVA DE DERECHOS Y DECLARACIÓN DE CONFLICTO DE INTERESES
El\La autor\a cede en forma gratuita y no exclusivo los derechos de distribución, reproducción y comunicación pública de la obra.
Las obras se publican en la edición electrónica de la revista bajo la licencia Creative Commons Atribución-No Comercial-Sin Obra Derivada 4.0 Internacional.
El\La autor\a cede a la Revista de la Secretaría de Posgrado de la Universidad Nacional de Quilmes, el derecho de publicar la obra respetando su contenido en otros soportes para otras ediciones (impresas o digitales).
El\La autor\a declara respetar los principios éticos a la investigación y no incurrir en ningún conflicto de intereses.